The PCCTC-managed IRONMAN Registry Deepens the Understanding of Racial Disparities in Pain and Survival in Individuals with Advanced Prostate Cancer

Jan 8

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 Trial of BioNTech-partnered BNT316/ONC-392 Program

The PCCTC-managed PROMISE Registry Manuscript Published In The Prostate.